Your session is about to expire
← Back to Search
Supportive Text Messaging for Mental Health Wellness (Text4Support Trial)
N/A
Recruiting
Research Sponsored by Vincent Agyapong
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 3, 6 and 12 months.
Awards & highlights
Text4Support Trial Summary
This trial will test whether a text messaging service can help improve mental health outcomes, satisfaction, and health services utilization for people accessing different degrees of psychiatric care.
Who is the study for?
This trial is for new or recently discharged patients from psychiatric care in Nova Scotia who own a mobile device, can read English text messages, and are willing to provide consent. It's not suitable for those unable to read texts in English or without a capable mobile phone.Check my eligibility
What is being tested?
The study tests if supportive daily text messages based on cognitive-behavioural therapy can improve mental health outcomes compared to usual care alone. Participants will be randomly assigned to receive either the text message program plus usual care or just the usual care.See study design
What are the potential side effects?
Since this intervention involves receiving supportive text messages, there are no direct physical side effects. However, participants may experience emotional discomfort if sensitive topics are touched upon in the texts.
Text4Support Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks, 3, 6 and 12 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 3, 6 and 12 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Generalized Anxiety Disorder
Change in Major Depressive Disorder
Change in Recovery
+2 moreSecondary outcome measures
Health services utilization (Emergency Department visits)
Health services utilization (crisis calls)
Health services utilization (hospital admissions)
+4 moreOther outcome measures
Implementation (acceptability)
Implementation (appropriateness)
Implementation (cost-effectiveness)
+2 moreText4Support Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Text4Support ArmExperimental Treatment1 Intervention
Patients in the intervention (Text4Support) arm of the study will receive the usual care (i.e. community care, follow-up appointments), plus daily automated supportive text messages from an online application.
Group II: Care as usual armActive Control1 Intervention
Patients in the control arm of the study will receive the usual care, which includes the freely accessible Health Authority approved low-intensity e-mental health services. They will receive a single text message informing and encouraging them to utilize current MHAP resources on the NS Health website. They will not receive automated daily supportive text messages.
Find a Location
Who is running the clinical trial?
Vincent AgyapongLead Sponsor
Nova Scotia Health AuthorityOTHER
263 Previous Clinical Trials
83,446 Total Patients Enrolled
10 Trials studying Depression
32,450 Patients Enrolled for Depression
Dalhousie UniversityOTHER
169 Previous Clinical Trials
402,154 Total Patients Enrolled
5 Trials studying Depression
30,548 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot read text messages in English.
Research Study Groups:
This trial has the following groups:- Group 1: Text4Support Arm
- Group 2: Care as usual arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger